Las Vegas, NV -- (SBWIRE) -- 01/24/2014 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Youku Tudou Inc (ADR) (NYSE:YOKU), Sequenom, Inc. (NASDAQ:SQNM), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Yamana Gold Inc. (USA) (NYSE:AUY).
Youku Tudou Inc (ADR) (NYSE:YOKU) ended its recent business day with the tumbled of -4.31% and closed at the price of $31.55 after opening at $30.93. The stock traded during its last trading session with the total volume of 9.37 million shares, as compared to its average volume of 2.94 million shares. Youku Tudou Inc. operates as an Internet television company in the Peoples Republic of China. Its Internet television platform enables consumers to search, view, and share video content across various devices.
Has YOKU Found The Bottom And Ready To Gain Momentum? Find Out Here
Sequenom, Inc. (NASDAQ:SQNM) remained among the day bearish -3.60% and traded with volume of 2.43 million shares in the last session, as compared to average volume of 2.16 million shares. In comparison with 52 week range of $1.65 - $4.90, it faced lowest price of $2.38 during the last trading session whereas its day highest price was $2.46. The company’s total market capitalization is $278.88 million, along with 115.72 million shares outstanding. Sequenom, Inc., a life sciences company, provides genetic analysis solutions in the United States and internationally. It operates through two segments, Molecular Diagnostics and Genetic Analysis.
Why Should Investors Buy SQNM After the Recent Fall? Just Go Here and Find Out
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) showed 5.25 million shares in volume during the last trading session, while the average trading volume remained 5.38 million shares. The stock kicked off its trading session at $7.49 and closed at $7.53 after rallied 0.53%. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
Why Should Investors Buy ARNA After The Recent Gain? Just Go Here and Find Out
Yamana Gold Inc. (USA) (NYSE:AUY) stock traded during its last trading session with the total traded volume of 9.20 million shares versus its average volume of 7.35 million shares. The company opened its trade at the price of $9.72 and its closing price was $9.63 after gained 0.84% for the day. Yamana Gold Inc. engages in the exploration, development, and production of mineral properties, primarily gold. It also explores for copper, molybdenum, zinc, and silver metals.
For How Long AUY will Fight for Profitability? Read This Trend Analysis report
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)